eIF3K Antibodies

Santa Cruz Biotechnology delivers a wide array of eIF3K monoclonal antibodies for investigating eIF3K's role in cellular processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF3K, a critical component of the eukaryotic translation initiation factor 3 (eIF3) complex, plays a significant role in the regulation of protein synthesis and cell growth. The involvement of eIF3K in translation initiation is essential for maintaining cellular homeostasis and responding to stress signals. Dysregulation of eIF3K has been linked to various diseases, including cancer, highlighting its significance as a potential therapeutic target. Research has shown that eIF3K functions extend beyond basic translation control, influencing cellular pathways and developmental processes. Understanding eIF3K's molecular mechanisms can provide valuable insights into disease progression and potential treatment strategies. Recent studies have revealed new roles for eIF3K in cellular signaling networks and stress response pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of eIF3K's role in health and disease.